Integrating Cryopreservation and Synthetic Seed Technologies for the Global Conservation and Exchange of Anti-aging Medicinal Plants

The rising global demand for anti-aging medicinal plants has intensified the need for advanced biotechnological approaches to ensure their long-term conservation, sustainable utilization, and equitable germplasm exchange. This chapter presents an integrative framework combining cryopreservation and synthetic seed technologies for the effective ex situ conservation of high-value species known for their therapeutic properties, including Withania somnifera, Curcuma longa, Phyllanthus emblica, Centella asiatica, Panax ginseng, and Ginkgo biloba. Emphasis is placed on optimized protocols, such as droplet vitrification, encapsulation-dehydration, and DMSO-based cryoprotection, for preserving critical tissues, including shoot tips, embryogenic calli, and pollen. In parallel, synthetic seed technology is discussed through the lens of encapsulation matrices and regeneration efficiency of somatic embryos and shoot buds. A bibliometric analysis of over 150 peer-reviewed publications (2000–2023), conducted using VOSviewer and Scopus/Web of Science datasets, identifies global research trends, collaborative networks, and underexplored taxonomic and geographic areas. Case studies from tropical and temperate bioregions illustrate practical applications, technology transfer pathways, and compliance with international treaties such as the Nagoya Protocol. The chapter concludes by outlining scalable strategies for commercial deployment, highlighting AI-assisted protocol optimization, public–private partnerships, and enabling policy frameworks. Together, these integrated approaches offer a climate-resilient and ethically grounded pathway for preserving the genetic diversity of medicinal plants threatened by overexploitation and environmental change.